arrow_back Trending Legislation
Share share

Improved Medicare Access to Innovative Diabetes Technologies

This act establishes a special task force to advise on access to modern technologies and services for individuals with diabetes covered by Medicare. The goal is to ensure patients have easier access to innovative solutions not fully covered by insurance, potentially improving their quality of life and treatment.
Key points
Creation of a task force within the Department of Health and Human Services to address access to innovative diabetes technologies under Medicare.
The task force will identify barriers to accessing new technologies and propose regulatory changes to facilitate Medicare coverage.
Ensuring Medicare beneficiaries with diabetes have equitable access to modern solutions, similar to those with private insurance.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021
Print number: S 2146
Sponsor: Sen. Collins, Susan M. [R-ME]
Process start date: 2021-06-21
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Improved Medicare Access to Innovative Diabetes Technologies

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 2146.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-06-21.

What are the main provisions?

Key points include:

  • Creation of a task force within the Department of Health and Human Services to address access to innovative diabetes technologies under Medicare.
  • The task force will identify barriers to accessing new technologies and propose regulatory changes to facilitate Medicare coverage.
  • Ensuring Medicare beneficiaries with diabetes have equitable access to modern solutions, similar to those with private insurance.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Collins, Susan M. [R-ME].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

Analysis and Potential Impact of S 2146

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health